Your browser doesn't support javascript.
loading
Radiotherapy in the treatment of middle ear and mastoid carcinoma.
Birzgalis, A R; Keith, A O; Farrington, W T.
  • Birzgalis AR; University Department of Otolaryngology, Manchester Royal Infirmary, UK.
Clin Otolaryngol Allied Sci ; 17(2): 113-6, 1992 Apr.
Article en En | MEDLINE | ID: mdl-1375135
ABSTRACT
The treatment of temporal bone carcinoma is a widely discussed topic with marked variation in published results. Most conclude that a combination of radical surgery and radiotherapy is the optimum treatment. The present study reviews the results of radiotherapy used as the main primary treatment for this condition. Five-year survival in 56 patients was 32% for radical and palliative therapy, with an excellent response in 'early' cases. It is concluded that improvement in survival could be attained by defining those groups which would benefit from a combination of treatment methods.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Neoplasias Craneales / Neoplasias del Oído / Carcinoma de Células Escamosas / Oído Medio / Apófisis Mastoides Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 1992 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Neoplasias Craneales / Neoplasias del Oído / Carcinoma de Células Escamosas / Oído Medio / Apófisis Mastoides Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 1992 Tipo del documento: Article